NAYA Biosciences
Wei Li, Ph.D., possesses extensive experience in the biotechnology field, currently serving as Chief Scientific Officer at Cytovia Therapeutics and holding board memberships at NAYA Biosciences and CytoLynx Therapeutics. Additionally, Wei Li contributes to the Scientific Advisory Board of Artus Therapeutics and has served as Chief Development Officer at OliX Pharmaceuticals, Inc. Wei Li's academic background includes a Postdoctoral fellowship in Rheumatology at Harvard Medical School and a Ph.D. in Molecular Virology from Georgia State University.
This person is not in any teams
This person is not in any offices
NAYA Biosciences
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. Our unique capabilities in biology, cell and gene therapy, and artificial intelligence provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough treatments.